Non-Survivor Ischemic Stroke Patients Maintain High Serum Caspase-Cleaved Cytokeratin-18 Levels.

Leonardo LorenteMaría M MartínAntonia Pérez-CejasAgustín F González-RiveroRafael SabatelLuis RamosMónica ArguesoJordi Solé-ViolánJuan J CáceresAlejandro JiménezVictor García-Marín

Published in: Brain sciences (2020)

The novel finding is that serum levels of CCCK-18 levels at any time after the first week of MMCAI could help predict 30-day mortality.

Keyphrases

cell death
cardiovascular events
risk factors
type diabetes
ischemia reperfusion injury
cardiovascular disease
clinical trial
induced apoptosis
coronary artery disease
brain injury
cerebral ischemia